Tuesday, December 30, 2025

Canada’s Politics and Government News Source Since 1989

Tuesday, December 30, 2025 | Latest Paper

Shared Services Canada ‘disappointed’ with Bell’s email contract delay

  Shared Services Canada’s email consolidation program, slated to begin in March has still yet to get underway and the government’s new mega-IT department says it’s because Bell, contracted to undertake the initiative, has been slow to the draw.  “Bell has not yet been able to meet the committed project deadlines,” said Ted Francis, the […]

Farmers’ seeds at centre of a debate over Agricultural Growth Act

  Farmers’ seeds are at the centre of a debate over Bill C-18, the Agricultural Growth Act. Proponents say this will align Canada with its international trade partners and allow for more private innovation in food biotechnology, while opponents say it will restrict farmers’ rights to save their seeds and place ownership in the hands […]

Doctors, researchers consider Orphan Drug Act ‘mission critical’

Despite having a late start in helping people with rare diseases access orphan drugs, Canada is now exceeding and becoming a world leader in some aspects in this field, particularly in genome studies, according to some in the field. According to the government, a rare disease is a life-threatening, seriously debilitating, or serious chronic condition […]

Labelling GMOs about transparency, not health say advocates

Advocates pushing for the government to adopt mandatory labelling regulation of genetically-modified foods may have received a boost, ironically, thanks to a recent Health Canada study.  On June 10, Health Canada released a report, “Consulting Canadians to Modernize and Improve Food Labels: What We Heard,” detailing what Health Canada has learned about Canadians’ priorities on […]

Biotech’s life sciences sector sees good news in CETA, but advocacy groups concerned about pharmaceutical R&D investments

  The life sciences sector of the biotechnology industry considers the Canada European Free Trade Agreement, which is expected to be initialed on Sept. 25 in Ottawa, good news for pharmaceutical innovation, but advocacy groups are concerned about how a continuing decline in Canadian pharmaceutical companies investment in research and development (R&D) will be addressed […]

CETA will provide extended protection for pharmaceutical innovators

Biotechnology is a diverse sector within Canada’s vibrant scientific community that is turning cutting-edge research into innovative products and processes including generating new energy through biofuels and biomass, increasing crop yields, and improving health-care treatments with new biopharmaceuticals.  Our government has ensured that Canada’s world-class researchers and competitive businesses thrive with targeted investments in research […]